Filing Flows › Neuraxis (NRXS) › Q2 2025
Neuraxis (NRXS) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
Neuraxis (NRXS) reported revenue of $894K for the second quarter 2025 (Q2 2025), +46% from a year earlier and -0.2% from the quarter before. Operating margin was -192.1%, net loss $1.7M (189.1% of revenue).
Neuraxis, Q2 2025: revenue $894K (+46% year over year), operating margin -192.1%, net loss $1.7M, operating cash flow −$1.5M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $894K | -0.2% | +46% |
| Operating profit | −$1.7M | — | — |
| Net earnings | −$1.7M | — | — |
| Operating cash flow | −$1.5M | — | — |
What changed
Revenue was $894K in Q2 2025, up 46% year over year and roughly flat from the previous quarter.
Gross margin was 83.6%, down 4.4 points from a year earlier. Operating costs exceeded revenue by $1.7M, an operating margin of -192.1%. Operating expenses fell 10% while revenue rose 46%. The fastest-growing cost line was Sales & marketing (+128%). The quarter ended with a net loss of $1.7M, narrower than the previous quarter's $2.3M loss.
Operating cash flow was −$1.5M. Non-cash charges added back $13K of depreciation and amortization and $173K of share-based compensation. Capital expenditures of $7K exceeded it, leaving free cash flow of −$1.5M.
Questions
What was Neuraxis' revenue in the second quarter 2025?
Neuraxis (NRXS) reported revenue of $894K for the second quarter 2025 (Q2 2025), +46% from a year earlier and -0.2% from the quarter before.
Was Neuraxis profitable in the second quarter 2025?
Operating loss was $1.7M (-192.1% of revenue) and net loss $1.7M.
Source: Neuraxis 10-Q on SEC EDGAR.